WELL Health Technologies (TSE:WELL) Price Target Raised to C$8.25

WELL Health Technologies (TSE:WELL) had its price target upped by stock analysts at Stifel Nicolaus from C$8.00 to C$8.25 in a research note issued to investors on Wednesday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 70.10% from the company’s current price.

Separately, Scotiabank dropped their target price on WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, WELL Health Technologies has a consensus rating of “Buy” and a consensus target price of C$6.92.

WELL Health Technologies Stock Down 0.6%

Shares of WELL traded down C$0.03 during mid-day trading on Wednesday, hitting C$4.85. 1,698,436 shares of the company’s stock were exchanged, compared to its average volume of 1,505,664. The company has a market cap of C$1.24 billion, a PE ratio of 44.09, a P/E/G ratio of -1.93 and a beta of 0.87. The company has a debt-to-equity ratio of 91.15, a current ratio of 0.83 and a quick ratio of 1.02. WELL Health Technologies has a 52 week low of C$3.58 and a 52 week high of C$6.08. The company has a 50-day simple moving average of C$4.06 and a 200 day simple moving average of C$4.05.

WELL Health Technologies (TSE:WELL) last released its quarterly earnings data on Thursday, May 7th. The company reported C$0.06 EPS for the quarter. WELL Health Technologies had a return on equity of 3.15% and a net margin of 1.82%.The company had revenue of C$368.26 million during the quarter. On average, research analysts forecast that WELL Health Technologies will post 0.3000698 earnings per share for the current fiscal year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.